Abstract
Urosepsis is defined as sepsis caused by urinary tract infection (UTI) and accounts for 25 % of all sepsis cases [1]. Patients with anatomical and/or functional abnormalities of the urinary tract and patients with comorbidities such as poor-regulated diabetes mellitus or immunosuppressive therapy are predisposed to sepsis syndrome [2]. Severe sepsis is a potentially life-threatening condition related to a mortality rate ranging between 30 and 50 % [3]. Hence, early goal-directed therapy and empirical antibiotic treatment are crucial aspects of patient care in urosepsis.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Wagenlehner FME, Pilatz A, Weidner W. Urosepsis–from the view of the urologist. Int J Antimicrob Agents. 2011;38(Suppl):51–7.
Grabe M (chair), Bartoletti R, Bjerklund-Johansen TE, Çek HM, Pickard RS, Tenke P, Wagenlehner F, Wullt B. European Association of Urology 2014. Guidelines on urological infections. Sepsis syndrome in urology (Urosepsis). 2014;(5):34–8.
Satran R, Almog Y. The coagulopathy of sepsis: pathophysiology and management. Isr Med Assoc J. 2003;5(7):516–20.
Assicot M, Gendrel D, Carsin H, Raymond J, Guilbaud J, Bohuon C. High serum procalcitonin concentrations in patients with sepsis and infection. Lancet. 1993;341(8844):515–8.
Wagenlehner FM, Lichtenstern C, Rolfes C, Mayer K, Uhle F, Weidner W, Weigand MA. Diagnosis and management for urosepsis. Int J Urol. 2013;20(10):963–70.
Nicolle LE. Urinary tract infection. Crit Care Clin. 2013;29(3):699–715.
Li L, Parwani AV. Xanthogranulomatous pyelonephritis. Arch Pathol Lab Med. 2011;135(5):671–4.
American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference. Definition for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med. 1992;20(6):86.
Glück T, Opal SM. Advances in sepsis therapy. Drugs. 2004;64(8):837–59.
Archana S, Vijaya C, Geethamani V, Savitha AK. Emphysematous pyelonephritis in a diabetic leading to renal destruction: pathological aspects of a rare case. Malays J Pathol. 2013;35(1):103–6.
Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, Sevransky JE, Sprung CL, Douglas IS, Jaeschke R, Osborn TM, Nunnally ME, Townsend SR, Reinhart K, Kleinpell RM, Angus DC, Deutschman CS, Machado FR, Rubenfeld GD, Webb S, Beale RJ, Vincent JL, Moreno R, Surviving Sepsis Campaign Guidelines Committee Including the Pediatric Subgroup. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med. 2013;39(2):165–228.
Yanar H, Taviloglu K, Ertekin C, Guloglu R, Zorba U, Cabioglu N, Baspinar I. Fournier’s gangrene: risk factors and strategies for management. World J Surg. 2006;30(9):1750–4.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Heidenreich, A., Thissen, A. (2014). Urosepsis. In: Merseburger, A., Kuczyk, M., Moul, J. (eds) Urology at a Glance. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-54859-8_10
Download citation
DOI: https://doi.org/10.1007/978-3-642-54859-8_10
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-54858-1
Online ISBN: 978-3-642-54859-8
eBook Packages: MedicineMedicine (R0)